CurveBeam AIASX:CVB Quick Ratio is 1.55 as of Dec. 2025, which is 2% above its 10-year median of 1.52. The stock has 5 warning signs investors should review. Among 854 Medical Devices & Instruments companies, CurveBeam AI ranks worse than 58.67% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. CurveBeam AI's quick ratio for the quarter that ended in Dec. 2025 was 1.55.
CurveBeam AI has a quick ratio of 1.55. It generally indicates good short-term financial strength.
The historical rank and industry rank for CurveBeam AI's Quick Ratio or its related term are showing as below:
ASX:CVB'
s Quick Ratio Range Over the Past 10 Years
Min: 0.28 Med: 1.52 Max: 1.97
Current: 1.55
During the past 5 years, CurveBeam AI's highest Quick Ratio was 1.97. The lowest was 0.28. And the median was 1.52.
ASX:CVB's Quick Ratio is ranked worse than 58.67% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs ASX:CVB: 1.55
CurveBeam AI (ASX:CVB) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
CurveBeam AI Quick Ratio Related Terms
CurveBeam AI Quick Ratio Historical Data
* Premium members only.
The historical data trend for CurveBeam AI's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CurveBeam AI's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CurveBeam AI Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Quick Ratio distribution charts can be found below:
* The bar in red indicates where CurveBeam AI's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
CurveBeam AI's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CurveBeam AI (ASX:CVB) has a Quick Ratio of 1.55 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on CurveBeam AI and its competitors. This is near median its historical median of 1.52. Over the past decade, CurveBeam AI's Quick Ratio has ranged from 0.28 to 1.97. According to the industry distribution chart, CurveBeam AI ranks #501 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 58.7%.
Is CurveBeam AI's Quick Ratio too high?
CurveBeam AI's current Quick Ratio of 1.55 is near median its 10-year median of 1.52. Over the past 10 years, this metric has ranged from a low of 0.28 to a high of 1.97. The Medical Devices & Instruments industry median Quick Ratio is 1.87. CurveBeam AI's value of 1.55 is 16.9% below this industry median. Based on the distribution chart, CurveBeam AI ranks #501 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does CurveBeam AI's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CurveBeam AI ranks #501 out of 854 companies for Quick Ratio. This places CurveBeam AI in the lower half of its industry. The industry median Quick Ratio is 1.87. CurveBeam AI's value of 1.55 is 16.9% below this benchmark. Historically, CurveBeam AI's own Quick Ratio has ranged from 0.28 to 1.97 over the past decade. While the company's 10-year median is 1.52 vs. the industry median of 1.87, CurveBeam AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CurveBeam AI's current Quick Ratio of 1.55 is 16.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on CurveBeam AI and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CurveBeam AI's current Quick Ratio is 1.55, which is near median its own 10-year median of 1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current Quick Ratio of 1.55. The current Quick Ratio is 1.55, which is near median its 10-year median of 1.52 and 16.9% below the Medical Devices & Instruments industry median of 1.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Quick Ratio is 1.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CVB has been successfully added to your 